The COPERNICUS research study
Learn about this study for adults with non-small cell lung cancer (NSCLC) that has spread.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It makes up about 85% of all lung cancer cases! This type of cancer happens when the cells in the lungs start to grow and divide out of control. This uncontrolled growth can cause different symptoms and may lead to serious health problems.
Doctors have several ways to treat NSCLC. Some of the common treatments include:
- Surgery: Removing the cancerous part of the lung.
- Chemotherapy: Using medicine to destroy cancer cells.
- Radiation therapy: Using high-energy rays to target and destroy cancer cells.
- Targeted therapy: Using drugs that target specific parts of cancer cells.
- Immunotherapy: Helping the body's immune system fight the cancer.
See if you may qualify
Answer the following questions to see if you or someone you know may be eligible to take part in this study.
Please keep in mind:
Even if you believe you meet the eligibility criteria, joining a clinical trial is not guaranteed. Whether you’re referred or able to take part depends on a review by a qualified healthcare professional.
About your information:
With your consent, we will use your answers to help determine whether you may be eligible for this clinical trial. You can withdraw your consent at any time.
Your information may be transferred to countries outside your country of residence, including the United States, which may have different data protection rules.
If you submit any personal information about someone else, you confirm that you have permission to do so.
Please read our Privacy policy for more details.